Breast Diagnostics
The diagnostic use of ultrasound has improved significantly because of improved resolution and reduction in artifacts, allowing increasingly more specific examination.
Breast cancer
Breast screening in the Netherlands
The Dutch screening programme, which began in 1990, invites women aged 50-75 years for mammography screening every two years. Today, the national programme is undergoing considerable regional re-organisation. As one of a team of 12 radiologists at the Alkmaar Medical Centre, Dr Shirley Go is responsible for Mammography and Screening in a large Dutch region. Daniela Zimmermann, asked Dr Go about…
SecondLook Digital - CAD software for Mammography
SecondLook Digital from iCAD is Philips' new computer aided detection solution for early breast cancer detection. It supports physicians in identifying and marking suspicious areas. The software performs optimally with both Philips DR and CR mammography solution and seamlessly integrates in Philips PACS and Philips viewing workstation MammoDiagnost VU.
MR Breast Care with Open Bore — and it's Pink!
On this years ECR Siemens Healthcare presents its dedicated MRI breast scanner. With it's pink design it immediately catches the eye on the company's booth. In an interview with EH, Boris Tolkien, Vice President Marketing Magnetic Resonance, Siemens Healthcare pointed out the highlights of the 1.5 Tesla system beyond its colour.
Breast cancers vary in complexity
Dr Giorgio Rizzatto, who heads the Department of Diagnostic Imaging at ASS 2 Isontina (including the Gorizia and Monfalcone hospitals) in NE Italy, works with nine radiologists, who examine and report on 80,000 clinical and screening breast examinations annually.
GE's new Discovery PET/CT 600 scanners go global
GE Healthcare's first Discovery PET/CT 600-series scanners are being installed in a number of leading clinics around the world. "This first set of installations is a big step forward in the diagnosis and monitoring of disease", said Terri Bresenham, newly appointed vice- president and general manager of GE Healthcare's global Molecular Imaging business.
New campaign for fair drugs testing aims to combat exploitation worldwide
The Netherlands - People in developing countries run health risks from pharmaceutical companies testing drugs on them for the Western market.
Biomarkers: What can they tell us?
Biomarkers are biochemical features or facets that can be used to measure the progress of disease or the effects of treatment.
Prostate Cancer Screening
To date, there is insufficient knowledge as to the cause of this disease, or how to prevent it. We asked some of our EH correspondents to report on measures taken in their countries to ensure that men are made more aware of this disease and whether screening services are provided for early prostate cancer detection.
The European Cancer Therapy Market
Cancer may well surpass cardiovascular diseases as the primary case of death in Europe by 2012. To prevent this from happening, cancer therapeutics have to shift in focus from the treatment of symptoms to offering a total cure, despite the complex, multifactorial nature of cancer indications.
US oncology expertise to spread globally
The University of Pittsburgh Medical Center and GE Healthcare plan to establish over 25 local cancer centres in various countries within the coming decade.
Tele-oncology proves successful in Canada
An estimated 6.7 million people in developed countries were diagnosed with cancer in 2007. Delivering their care is no easy matter. Tele-oncology, the remote provision of oncology services, could not only reduce the costs of consultations for cancer departments, but also for patients. Kerry Heacox, of i.t. Communications, reports on the success of remote consultations in Labrador and Newfoundland.…
EPPENDORF and MEDICA
When the first `diagnostics week´ was held 40 years ago the exhibition attracted just a handful of companies, all from the laboratory sector. At the time, no one could have known that this sedate event would eventually develop into the world's biggest medical exhibition, MEDICA.
Lumpectomy is not advised if breast cancer returns
A mastectomy is prudent when breast cancer returns after a lumpectomy, because survival rates are higher for those who have another lumpectomy, according to a new study published in the American Journal of Surgery in October.
Breast cancer
Olwen Glynn Owen reports on MammaPrint, a test that pinpoints the risk of breast cancer recurrence from the primary tumour's genetic make-up. Women with breast cancer tumours under
Mammography: What really counts?
The fact that the female breast is one of the most radiation sensitive organs in the human body is a major driver for all those searching for low radiation alternatives - one of these routes lies in photon counting.
Siemens opens Cologne research centre
Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.
Radiation dose and digital mammography
The use of mammography to maintain breast health comes with a caveat: exposure of the breast to radiation, which can increase the susceptibility risk of breast cancer. Thus, using the lowest possible radiation dose for mammograms is of utmost importance.
Core needle beast biopsies safe for patients taking blood thinners
It is safe to take anticoagulants before core needle breast biopsies, according to a study performed at the Elizabeth Wende Breast Clinic in Rochester, NY.
Better treatment by computer-based decisions?
The US Agency for Healthcare Research and Quality (AHRQ) will fund a new project to develop four computer-based decision-tools that will help clinicians and patients answering questions like: When to use genetic tests? How to deal with the results? Or which treatment could be the best?
Better images for X-ray mammography with new tool
Fighting breast cancer is always a race against time - early detection of breast carcinoma an essential condition for cure. Now Scientists from Finland, Germany and France developed a promising new CT technique with high resolution and contrast that visualises tumours that are even diffusely growing or those in dense breasts.
Breast cancer: new method is more effective than mammography in women with dense breasts
“Molecular breast imaging” (MBI), a new scintigraphy method developed by US researchers, might improve early detection of breast cancer in women with dense breasts. The results of an initial clinical study were recently presented at the Breast Cancer Symposium of the American Society of Clinical Oncology (ASCO) in Washington, DC, USA.
Drug might protect against tumour recurrence
Tumour cells can migrate, sometimes also during a surgery to remove the tumour. US researchers recently found, that perioperative treatment with a drug known as colchicine might protect against recurrences at the site of the surgical wound.
Welcome to ESTRO 27
More than 4,500 cancer and radiotherapy specialists will gather in Göteborg, Sweden, this September for the 27th annual congress of ESTRO. ESTRO 27 is to be held between the 14th and 18th September 2008 at the Göteborg Convention Centre in Göteborg.
Breast cancer: Good news, bad news
Women who survive breast cancer for at least five years have a 89% chance that it will not recure. But those, who are still suffering and on endocrine treatment are likely to get arthralgia and arthritis.
